Celularity receives Nasdaq notice of market-value listing deficiency
Celularity received notice from Nasdaq on June 9, 2026, that its market value of listed securities fell below the $35 million minimum required for continued listing on the Nasdaq Capital Market. The company has 180 calendar days, until December 7, 2026, to regain compliance by achieving a market value of at least $35.0 million for 10 consecutive business days. The notice does not result in immediate delisting; if the company fails to comply by the deadline, it will receive a delisting determination and may appeal.
Key facts
- Market value of listed securities fell below $35 million minimum for 30 consecutive business days prior to June 9, 2026
- Compliance deadline: December 7, 2026 (180 calendar days from notice)
- Company must achieve market value of at least $35.0 million for 10 consecutive business days to regain compliance
- Nasdaq Listing Rule 5550(b)(2) sets the $35 million MVLS requirement
- Company may consider increasing stockholders equity to at least $2.5 million as an alternative compliance path
- Failure to comply by December 7, 2026 will trigger a delisting determination notice, which may be appealed
Why it matters
Celularity has a defined six-month window to restore its market capitalization above $35 million or pursue alternative compliance measures; failure to do so will trigger a formal delisting process, though the company retains the right to appeal.
Developing story
- NT 10-Q
- SCHEDULE 13D
- NT 10-K
- 8-Kthis filing
Share
Get the next chapter in your inbox — a Sentinel watches this company and briefs the next material filing the moment it lands.
Derived from 8-K filed 2026-06-12. Not investment advice. View the source filing on SEC.gov →